CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE

The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dop...

Full description

Saved in:
Bibliographic Details
Main Authors Henry, Rodger F, Ho, Raimundo, Huang, Ye, Dempah, Kassibla E, Chan, Vincent S, Cardinal-David, Benoit, Wang, Zhi, Zhang, Geoff G, Stella, Valentino J, Huters, Alexander D, Krabbe, Scott W, Lao, Yanbin, Mayer, Peter T, Enright, Brian P, Lou, Xiaochun, Mackey, Sean E, Matulenko, Mark A, Stambuli, James, Miller, Christopher P, Voight, Eric A, Klix, Russell C, Kym, Philip R
Format Patent
LanguageCroatian
English
Published 18.10.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.
Bibliography:Application Number: HR2019P001285T